Cargando…

Molecular targets of luteolin in cancer

Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses ex...

Descripción completa

Detalles Bibliográficos
Autor principal: Tuorkey, Muobarak J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885545/
https://www.ncbi.nlm.nih.gov/pubmed/25714651
http://dx.doi.org/10.1097/CEJ.0000000000000128
_version_ 1782434521754370048
author Tuorkey, Muobarak J.
author_facet Tuorkey, Muobarak J.
author_sort Tuorkey, Muobarak J.
collection PubMed
description Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses existing data on luteolin’s anticancer activities and then offers possible explanations for and molecular targets of its cancer-preventive action. Luteolin prevents tumor development largely by inactivating several signals and transcription pathways essential for cancer cells. This review also offers insights into the molecular mechanisms and targets through which luteolin either prevents cancer or mediates cancer cell death.
format Online
Article
Text
id pubmed-4885545
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-48855452016-06-15 Molecular targets of luteolin in cancer Tuorkey, Muobarak J. Eur J Cancer Prev Review Article: Carcinogenesis Many food-derived phytochemical compounds and their derivatives represent a cornucopia of new anticancer compounds. Despite extensive study of luteolin, the literature has no information on the exact mechanisms or molecular targets through which it deters cancer progression. This review discusses existing data on luteolin’s anticancer activities and then offers possible explanations for and molecular targets of its cancer-preventive action. Luteolin prevents tumor development largely by inactivating several signals and transcription pathways essential for cancer cells. This review also offers insights into the molecular mechanisms and targets through which luteolin either prevents cancer or mediates cancer cell death. Lippincott Williams & Wilkins 2016-01 2015-12-02 /pmc/articles/PMC4885545/ /pubmed/25714651 http://dx.doi.org/10.1097/CEJ.0000000000000128 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
spellingShingle Review Article: Carcinogenesis
Tuorkey, Muobarak J.
Molecular targets of luteolin in cancer
title Molecular targets of luteolin in cancer
title_full Molecular targets of luteolin in cancer
title_fullStr Molecular targets of luteolin in cancer
title_full_unstemmed Molecular targets of luteolin in cancer
title_short Molecular targets of luteolin in cancer
title_sort molecular targets of luteolin in cancer
topic Review Article: Carcinogenesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885545/
https://www.ncbi.nlm.nih.gov/pubmed/25714651
http://dx.doi.org/10.1097/CEJ.0000000000000128
work_keys_str_mv AT tuorkeymuobarakj moleculartargetsofluteolinincancer